Clinical Trials for: bimatoprost
Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo
Status: Completed Condition: Hypotrichosis
Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata
Status: Completed Condition: Alopecia Areata
Eyelash Growth From Application of Bimatoprost in Gel Suspension to the Base of the Eyelashes
Status: Completed Condition: Hypertrichosis
Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia
Status: Completed Condition: Alopecia; Alopecia, Androgenetic; Baldness
Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-Weeks, Masked Evaluator, Phase IV Multi-Center Study in the US
Status: Completed Condition: Glaucoma; Ocular Hypertension
Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose
Status: Recruiting Condition: Primary Open Angle Glaucoma; Ocular Hypertension
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
|SOLUTION/DROPS;OPHTHALMIC||022184||Aug 31, 2010||RX||Yes||5,688,819||<disabled>||LUMIGAN IS A PROSTAGLANDIN ANALOG INDICATED FOR THE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION|
|SOLUTION/DROPS;OPHTHALMIC||022184||Aug 31, 2010||RX||Yes||8,299,118||<disabled>||A METHOD OF TREATING A PATIENT WITH GLAUCOMA OR OCULAR HYPERTENSION|
|SOLUTION/DROPS;OPHTHALMIC||022184||Aug 31, 2010||RX||Yes||8,309,605||<disabled>||METHOD OF TREATING GLAUCOMA IN A PATIENT|
|SOLUTION/DROPS;OPHTHALMIC||022184||Aug 31, 2010||RX||Yes||8,309,605||<disabled>||A METHOD OF LOWERING INTRAOCULAR PRESSURE IN A PATIENT WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION|
|This preview shows a limited data set|
Complete access is available with a Subscription
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639